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Failure of Present Clinical Algorithms of 
Intravenous Heparin Adjustment to Maintain Stable 
Therapeutic Anticoagulation in a Coronary Care 
Unit Setting
Joseph B. Muhlestein, Tami L. Bair, Labros A. Karagounis, Jeffrey 
L. Anderson. University of Utah, LDS Hospital, Salt Lake City, Utah
intravenous heparin anticoagulation in the coronary care unit is very common. 
Although a wide variety of anticoagulation algorithms, with and without weight 
adjustment, have been described, their efficacy is in question. To determine 
the effectiveness of presently existing clinical heparinization protocols, we 
studied the results of 3,745 consecutive patients (mean age: 64 yrs, males: 
72%, average weight: 82 kg, admitted with acute Ml: 63%) receiving IV 
heparin in the LDS Hospital CCU. Time from initiation of heparin to the first 
therapeutic PTT (defined as 60-90 sec) (TFTPTT), % of PTT’s < 60, % of 
PTT’s > 90, and the total % of PTT's outside the therapeutic range (%OTR) 
were evaluated for the entire group and for subsets of patients in which the 
initial weight adjusted dosing was within three ranges of < 12 U/kg/hr, 12-17 
U/kg/hr, and > 17 U/kg/hr, Results are:
Initial Heparin Dose TFTPTT %PTTs < 60 % PTT's >90 %OTR
< 12 U/kg/hr (n = 
12-17 U/kg/hr (n 
> 17 U/kg/hr ( n = 
Entire Group (n =
1348)
» 2060)
337)
3745)
10.6±11.8hr 
7.8±9.0hr 
7.1 ±7.5hr 
9.5 ±  9.9hr
48 ± 28% 
35 ± 24% 
31 ± 24% 
39 ± 26%
21 ±  23% 
31 ±  25% 
36 ±  26% 
28 ±  24%
69 ±  24%
66 ±  24%
67 ±  22% 
67 ±  24%
Conclusion: Two thirds or more of PTT’s obtained in the CCU in all groups 
of patients on IV heparin were found to be out of range. Although patients 
treated in the more aggressive weight adjustment ranges tended to reach a 
therapeutic PTT sooner than those treated in the lower range, this difference 
is likely not large enough to show clinical relevance. This study underscores 
the difficulty of maintaining stable adequate anticoagulation in clinical practice 
using IV heparin, regardless of whether weight adjustment is used, and the 
need to evaluate alternative more stable anticoagulation strategies.
Treatment of Intracoronary Thrombus: Successful 
Lysis With Intra-Coronary t-PA
Barry L. Sharaf, George R. McKendall, Ted W. Love, Robert Bersin,
David Talley, David O. Williams for the Intracoronary t-PA Investigators. 
Rhode Island Hospital, Brown University, Providence, Rhode Island
In order to assess the efficacy of intracoronary (IC) t-PA we reviewed in a core 
laboratory the coronary angiograms at baseline, 20,40,60 minutes (min) and 
24 hours after treatment of 120 patients (pts) with acute coronary syndromes 
and IC thrombus. Thrombus was scored as none (0), possible (1) and definite 
(2-4) with discrete intra-luminal filling defects of increasing size (small < 1/2, 
moderate > 1/2 + < 2, and large > 2 vessel diameters respectively). Five IC 
t-PA infusion strategies were assessed (20 mg bolus, 20 mg over 20 min, 20 
mg over 40 min, 40 mg over 20 min and 40 mg over 40 min). For the entire 
cohort, percent stenosis (84 ±  15 baseline vs 75 ±  20 at 24 hr) and TIM I flow 
(58% with grade 3 baseline vs 69% at 24 hr) improved with therapy.
Angiographic Outcome Baseline 60 min 24 hr
No clot (%) 7 15 26
Definite clot (%) 79 63 47
Large clot (%) 33 21 11
Procedural and angiographic variables were analyzed to predict successful 
lysis. A decrease of > 2 thrombus scores at 24 hr was noted in 55% of pts 
with TIM I 3 flow at baseline compared to 33% of pts with TIM! 0-2 flow (p -  
0.05). A decrease of > 2 thrombus scores at 24 hr was noted In 56% of pts 
treated with high dose (40 mg) t-PA compared to 40% of pts treated with low 
dose (20 mg) t-PA (p *  0.14). We conclude that IC t-PA relieves coronary 
narrowing, improves flow, successfully lyses IC clot at low dose with some 
added benefit from high dose and that its effectiveness is dependent on 
pre-treatment flow.
Regression of Culprit Coronary Lesions 
Demonstrated by Repeat Quantitative Coronary 
Angiography Within Three Months After 
Thrombolysis for Acute Myocardial Infarction
Gerrit Veen, Carel C. de Cock, Freek W.A. Verheugt, Department of 
Cardiology, Free University Hospital, Amsterdam, The Netherlands
Little is known about the natural history of coronary lesions after successful 
thrombolysis (T) for acute myocardial infarction (Ml). In the APRICOT-study 
we performed coronary angiography within 48 hours after T and patients 
(pts) with a patent infarct-reiated artery underwent a second angiography 
after 3 months. Initial visual assessment showed high-grade stenosis to 
be an independent predictor of reocclusion. We also found that 15% of 
complex lesions showed remodelling to smooth and less severe lesions. 
Quantitative coronary angiography (QCA) was performed to obtain accurate 
data concerning reocclusion and regression of culprit lesions.
In 230 of 248 pts the angiograms were suitable for QCA. In this group 66 
pts showed reocclusion. The mean diameter stenosis of the culprit lesions 
in pts with reocclusion was 61.4 ±  10.7% compared to 54.4 ±  11.7% in 
pts without reocclusion (p < 0.0001). The table shows data of 161 pts 
without reocclusion. Three subgroups were studied according to changes in 
morphology. (Only three lesions changed from smooth to complex and were 
not considered in this analysis).
Morphol. change Mean diameter stenosis (%) P
Angio 1 Anglo 2
CO-»- CO <N-  41) 55.8 ±11.2 50.5 ±10.9 0.002
CO -» SM {N = 38) 52.6 ±12.1 40.3 ± 16.3 0.00001
SM -*-+ SM (N = 82) 54.4 ±12.0 51.2±  14.0 0.01
SM *  smooth; CO = complex
Conclusion: QCA confirms that stenosis severity measured early after 
successful T for acute Ml is associated with reocclusion.' In pts without 
reocciusion reduction in stenosis severity occurs in most lesions. However, 
the largest reduction is seen in lesions changing from complex to smooth, 
implicating that these lesions are especially subject to ongoing thrombus 
resolution and plaque repair.
identification of High-Risk Patients With Unstable 
Angina
Giorgio Ghigliotti, Claudio Brunelll, Luca Corsiglia, Paolo Spallorossa, 
Alessandro lannone, Salvatore Caponnetto. Department of Cardiology, 
Genova, Italy
Early revascularization has been proposed in patients with unstable angina 
(UA) who have in-hospital recurrence of symptomatic ischemia despite bed 
rest and aggressive medical therapy. In our ward, mean waiting times for 
revascularization of over 2 weeks allowed for assessment of: 1) the risk in 
delaying revascularization for more than 72 to 96 hrs, and 2) whether patient 
risk for recurrent ischemia could be defined. We graded recurrent angina as 
refractory (Group 1) when pts had > one ischemic episode/day over con­
secutive 48 hours and > five episodes total, and as occasional (Group 2) 
when pts had > one ischemic episode without the previous features. Of 335 
consecutive pts with UA who were admitted to our ward, 109 (32.6%) had 
recurrent ischemia (33 pts in Group 1,76 in Group 2). Significant differences 
(p < 0.05) between pts in Groups 1 and 2 were found for females (49% 
vs 29%), insulin-dependent diabetes (9% vs 1%), triple/left main coronary 
disease (43% vs 23%), mean ejection fraction (57 ±  17% vs 64 ±  12%), 
and episodes of ischemia: lasting more than 20 min (94% vs 40%), with ar- 
rythmias (27% vs 11%) or requiring Inotropic drug (18% vs 4%). The waiting 
times for revascularization were similar (22 ±  13 vs 17 ±  7 days). In Group 
1, 11 of 17 pts treated medically were angina-free after 16 ±  8 days, but 
six (18.1%) had intercurrent events (two deaths within 96 hrs despite rescue 
revascularization); the remaining 16 pts underwent revascularization safely, 
in Group 2, 62 of 67 pts treated medically had resolution of ischemia after 5 
±  5 days, but five patients (6.6%) had events (two within 96 hrs of admis­
sion); the 10 remaining pts had successful revascularization. Conclusions: 
1) patients with recurrent ischemia after 48 hrs of medical therapy should be 
referred for immediate angiography; 2) delaying revascularization In these 
patients more than 96 hrs increases the risk of cardiac events; 3) refractory 
UA may be defined by the persistence of ischemic episodes despite 4 to 7 
days of medical therapy.
